Long-term and low-dose busulfan is safe and effective in elderly patients with essential thrombocythemia

Category Primary study
JournalHaematologica
Year 2017
This article has no abstract
Epistemonikos ID: d133d577d4eec64e45883307b9cc76c54bc5dd4c
First added on: Feb 08, 2025